Reto Brun

Research.com Recognitions

• 2023 - Research.com Biology and Biochemistry in Switzerland Leader Award

Overview

Best Publications

• Spiroindolones, a Potent Compound Class for the Treatment of Malaria

  Matthias Rottmann;Matthias Rottmann;Case McNamara;Bryan K.S. Yeung;Marcus C.S. Lee

  1308
  Citations

• Antimalarial drug discovery: efficacy models for compound screening

  David A. Fidock;Philip J. Rosenthal;Simon L. Croft;Reto Brun

  1214
  Citations

• Human African trypanosomiasis

  Reto Brun;Johannes Blum;Francois Chappuis;Francois Chappuis;Christian Burri

  1092
  Citations

• The Alamar Blue® assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro

  B Räz;M Iten;Y Grether-Bühler;R Kaminsky

  1020
  Citations

• Identification of an antimalarial synthetic trioxolane drug development candidate.

  Jonathan L Vennerstrom;Sarah Arbe-Barnes;Reto Brun;Susan A Charman

  773
  Citations

• Kinetoplastids: related protozoan pathogens, different diseases

  Ken Stuart;Reto Brun;Simon Croft;Alan Fairlamb

  773
  Citations

• Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues: In Vitro, In Vivo, Structure-Activity Relationship, and Quantitative Structure-Activity Relationship Studies

  Deniz Tasdemir;Marcel Kaiser;Reto Brun;Vanessa Yardley

  475
  Citations

• Spirotetrahydro β-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria.

  Bryan K S Yeung;Bin Zou;Matthias Rottmann;Suresh B Lakshminarayana

  470
  Citations

• Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

  Susan A. Charman;Sarah Arbe-Barnes;Ian C. Bathurst;Reto Brun

  455
  Citations

• Human African trypanosomiasis: pharmacological re-engagement with a neglected disease

  M P Barrett;D W Boykin;R Brun;R R Tidwell

  440
  Citations

• Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness

  Els Torreele;Bernadette Bourdin Trunz;David Tweats;David Tweats;Marcel Kaiser;Marcel Kaiser

  389
  Citations

• Trypanosoma evansi and T. equiperdum: distribution, biology, treatment and phylogenetic relationship (a review)

  Reto Brun;Hermann Hecker;Zhao-Rong Lun

  352
  Citations

• SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis.

  Robert T. Jacobs;Bakela Nare;Stephen A. Wring;Matthew D. Orr

  348
  Citations

• The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases – Part I

  T. J. Schmidt;S. A. Khalid;A. J. Romanha;T. Ma. Alves

  346
  Citations

• A simple monophasic medium for axenic culture of hemoflagellates.

  Randy L. Berens;Reto Brun;Stuart M. Krassner

  298
  Citations

• Eflornithine for the treatment of human African trypanosomiasis.

  Christian Burri;Reto Brun

  289
  Citations

• Ancistrotanzanine C and related 5,1'- and 7,3'-coupled naphthylisoquinoline alkaloids from Ancistrocladus tanzaniensis.

  Gerhard Bringmann;Michael Dreyer;Johan H. Faber;Petur Weihe Dalsgaard

  260
  Citations

• Evaluation of African medicinal plants for their in vitro trypanocidal activity

  F. Freiburghaus;R. Kaminsky;M.H.H. Nkunya;R. Brun

  258
  Citations

• The phenomenon of treatment failures in Human African Trypanosomiasis

  Reto Brun;Reto Schumacher;Cecile Schmid;Christina Kunz

  254
  Citations

• Critical roles of glycosylphosphatidylinositol for Trypanosoma brucei

  Kisaburo Nagamune;Tomoyoshi Nozaki;Yusuke Maeda;Kazuhito Ohishi

  245
  Citations

• 45 – Human African Trypanosomiasis

  Christian Burri;François Chappuis;Reto Brun

  8
  Citations